With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...

A new study led by researchers from Boston University Chobanian & Avedisian School of Medicine has found there is no consensus in how clinical experts interpret CGM reports from people without ...

DexCom , Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) systems for diabetes management with a market capitalization of $34.8 billion, finds itself at a critical juncture as it ...

Exercise is essential for managing diabetes and reducing the risk of heart disease. Regular physical activity helps combat ...

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

Circadian Health, a pioneering leader in virtual-first specialty care, has been named a Winner in the 2025 HLTH Foundation's 2nd Annual Techquity for Health Case Study Awards for its work in ...

Looking forward, DexCom's management has reiterated its fiscal year 2025 forecast, anticipating revenue growth of 14% with a ...

The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...

MDT delivers strong earnings in the fiscal 2025 third quarter, with significant improvements in both gross and operating margins.